RE: Dog Share28 Jun 2023 11:39
Sucks to hear you're underwater on this. If you were hoping for a quick profit after the OTC listing, I'm sure you'd be very disappointed on the results. I think everyone here is a bit surprised, but for myself it doesn't change much.
I am in for the long. If the trials reveal a strong link between the patents GENF hold and longevity, this is will likely be my early retirement. Even if it just gives us a NASH treatment, I can see the share yielding very positive results.
Two years of funding and such great developments in the last year alone. At 2.5p this is an absolute bargain to me, and I'll happily continue to build my stake at that price point. It's not for everyone, your mileage may vary. Good luck